Observational Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Feb 16, 2024; 12(5): 951-965
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.951
Figure 5
Figure 5 Metabolites involved in Helicobacter pylori elimination. A: Peak intensity of the significant urinary metabolites associated with chronic gastritis management during Helicobacter pylori (H. pylori) elimination. Data presented as the mean ± SD (n = 20). P < 0.05 was considered to represent significance. Health group vs H. pylori-positive [HP(+)] group: aP < 0.05, bP < 0.01, cP < 0.001, and dP < 0.0001; HP(+) group vs H. pylori-negative group: eP < 0.05, fP < 0.01, and gP < 0.0001; B: Receiver operating characteristic curve analysis of seven identified biomarkers. Helicobacter pylori-positive; HP(−): Helicobacter pylori-negative.